Ezetimibe Tablet
Product Images NDC 0904-7103

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 0904-7103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (E257ed7f 5015 4f1d 93f4 5adf5797643d 00)

Label for Ezetimibe tablets, USP 10 mg oral dosage form by Major Pharmaceuticals. The label states the product is prescription-only with a 30-tablet unit dose package. It includes storage instructions and manufacturer and distributor information from Major Pharmaceuticals, Livonia, MI, and Ascend Laboratories, NJ.*

FDA Label Image

Ezetimibe-structure (Ezetimibe Structure)

Chemical structure diagram of the active ingredient Ezetimibe, showing its molecular configuration with aromatic rings, hydroxyl groups, fluorine atoms, and a beta-lactam ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.